Program

Program

The Program is Preliminary and is a subject to change.

Please note in the virtual platform a number of  presentation slides will only be shown during the live streaming, upon speakers request.

Pre-registration and separate payment is required.

Nicola Segata, University of Trento, Italy
Curtis Huttenhower, Harvard University, USA
Mireia Valles-Colomer, University of Trento, Italy
Meg Short, Harvard University, USA
Francesco Asnicar, University of Trento, Italy
Philipp MĂĽnch, Harvard University, USA

Chairs: Kjersti Aagaard, Baylor College of Medicine, USA
& Omry Koren, Bar Ilan University, Israel

16:15 - 16:45
Microbial influence on linear growth
Francois Leulier, Ecole Normale Supérieure de Lyon, France

16:45 - 17:15
Discovering next generation beneficial bacteria to improve cardiometabolic disorders: from bench to bedside
Patrice Cani, UCLouvain, Belgium

17:15 - 17:25
Panel Discussion

Chairs: David MacIntyre, Imperial College London, United Kingdom
& Florent Ginhoux, Singapore Immunology Network, Singapore

17:30 - 17:45
Microbial exposure during early human development primes fetal immune cells
Florent Ginhoux, Singapore Immunology Network, Singapore

17:45 - 18:00
Đśaternal microbiota and factors shaping Mother-to-Infant Transmission early in life
Maria Carmen Collado, Spanish National Research Council, Spain

18:00 - 18:15
Transmission of maternal microbes during birth and impact on child health
Jacob Stokholm, COPSAC, Denmark

18:15 - 18:25
Antenatal antibiotic-induced maternal dysbiosis is transferred to offspring during critical developmental window
Stephanie Prescott, University of South Florida, USA

18:25 - 18:35
Factors shaping the human milk microbiota and oligosaccharide composition
Johanne Spreckels, University Medical Center Groningen, The Netherlands

18:35 - 19:05
Panel Discussion

Chair: Patrice Cani, UCLouvain, Belgium
& Eran Segal, Weizmann Institute of Science, Israel

17:30 - 17:45
Safety and regulatory concerns for live bacterial products
Elizabeth Hohmann, Harvard Medical School, USA

17:45 - 18:00
FMT for cancer treatment
Gianluca Ianiro, University of Sacro Cuore, Italy

18:00 - 18:20
Microbial Modulation of Histamine Signaling and Intestinal Inflammation
Jаmes Versalovic, Texas Children’s Hospital and Baylor College of Medicine, USA

18:20 - 18:30
A phase 2, double-blind, placebo-controlled study of the safety and efficacy of microbial ecosystem therapeutic-2 (MET-2) in patients with major depression: protocol and preliminary results
Arthi Chinna Meyyappan, Queen's University, Canada

18:30 - 19:00
Panel Discussion

Chairs: David Berry, University of Vienna, Austria
& Jaana Rautava, University of Helsinki, Finland

17:30 - 17:45
Transmission of the oral microbiome
Mireia Valles-Colomer, University of Trento, Italy

17:45 - 18:00
Microbiomes in the digestive tract of ancient human remains: oral and gut microbiota
Frank Maixner, EURAC Institute for Mummy Studies, Italy

18:00 - 18:15
On the transition from healthy to dysbiotic oral microbiome in young children
Egija Zaura, Academic Centre for Dentistry Amsterdam, The Netherlands

18:15 - 18:25
Evolution of distinct microbiota signatures in upper airway and buccal mucosae of Chinese infants
Ting Fan Leung, The Chinese University of Hong Kong, Hong Kong PRC

18:25 - 18:55
Panel Discussion

Chairs: Kjersti Aagaard, Baylor College of Medicine, USA
& Rochellys Diaz Heijtz, Karolinska Institutet, Sweden

08:30 - 08:45
Infant gut microbiome and BMI & Neurodevelopmental outcomes in adolescence- lessons from a longitudinal study
Merete Eggesbø, Norwegian Institute of Public Health, Norway

08:45 - 09:00
Human microbiota - mediating adaptation to change
Erika Isolauri, University of Turku, Finland

09:00 - 09:15
siRNA screening to reveal host receptors for the binding of Bifidobacterium bifidum
Reetta Satokari, University of Helsinki, Finland

09:15 - 09:30
The microbiome in the first 1000 days of life: teasing out causality
Omry Koren, Bar Ilan University, Israel

09:30 - 09:40
Early-life formula feeding is associated with infant gut microbiota alterations and an increased antibiotic resistance load
Katariina Pärnänen, University of Helsinki, Finland

09:40 - 09:50
Feeding the microbiome: triangulating the influence of diet on the infant microbiota and metabolome
Colin Bruce, McMaster University, Canada

09:50 - 10:30
Panel Discussion

Chair: David Berry, University of Vienna, Austria & Mindy Engevik, Medical University of South Carolina, USA

09:00 - 09:15
Microbiota-targeted dietary interventions in patients with inflammatory bowel disease
Lihi Godny, Rabin Medical Center, Israel

09:15 - 09:30
Mucosal integrity in the gut
Mindy Engevik, Medical University of South Carolina, USA

09:30 - 09:50
Personalized medicine based on microbiome and clinical data
Eran Segal, Weizmann Institute of Science, Israel

09:50 - 10:00
Microbially conjugated bile acids as a novel language in the host/microbiome crosstalk
Robert Quinn, Michigan State University, USA

10:00 - 10:30
Panel Discussion

Chairs: Nicola Segata, University of Trento, Italy
& Daniel Belstrøm, University of Copenhagen, Denmark

09:00 - 09:20
Oral Microbiome Biogeography: The Site-Specialist Hypothesis
Gary G. Borisy, Forsyth Institute, USA

09:20 - 09:35
The mouth is not Vegas, what happens here does not stay here
Purnima Kumar, The Ohio State University, USA

09:35 - 09:45
Microbial signatures in the oral microbiome as a potential tool in forensic human identification
Nengi Ogbanga, Northumbria University, UK

09:45 - 10:15
Panel Discussion

10:35 - 10:55
Non-CME Product Theatre (not included in the main event CME/CPD credit offering).

Chair: Reetta Satokari, University of Helsinki, Finland
& Nissan Yissachar, Bar-Ilan University, Israel

11:00 - 11:15
Microbiota, maternal-fetal interactions and cognitive development
Rochellys Diaz Heijtz, Karolinska Institutet, Sweden

11:15 - 11:30
Role of early-life microbiota in the development of barriers across the gut-brain axis
Maria Rodriguez Aburto, University College Cork, Ireland

11:30 - 11:45
Gut microbes, Bookends of life and Biological Ageing
Sven Pettersson, Lee Kong Chian School of Medicine, Singapore

11:45 - 12:00
Results of a randomized double-blind controlled clinical study on a probiotic treatment for women after pregnancy, to reduce postpartum baby-blues and improve breastfeeding quality
Franco Vicariotto, Humanitas-San PIO X Hospital Milan, Italy

12:00 - 12:25
Panel Discussion

Chairs: Iris Dotan, Rabin Medical Center, Israel
& Jаmes Versalovic, Texas Children’s Hospital and Baylor College of Medicine, USA

11:00 - 11:15
The role of the microbiome in post-operative recurrence of Crohn’s disease
Matthieu Allez, Saint-Louis and Lariboisière Hopitals, France

11:15 - 11:30
The complexity of resistance: lessons learned from antibiotic therapy in pouchitis
Uri Gophna, Tel Aviv University, Israel

11:30 - 11:45
The unique multi-layered practical challenge of IBD surgery
Ian White, Rabin Medical Center, Israel

11:45 - 11:55
Fungal and bacterial gut microbiota in patients with paediatric onset inflammatory bowel disease introduced to infliximab
Rebecka Ventin-Holmberg, University of Helsinki, Finland

11:55 - 12:25
Panel Discussion

Chairs: Samuli Rautava, University of Turku, Finland
& Purnima Kumar, The Ohio State University, USA

11:00 - 11:15
The oral microbiome and cardiovascular risk factors and indicators
Daniel Jönsson, University of Malmö, Sweden

11:15 - 11:30
Strong oral plaque microbiome signatures for dental implant diseases identified by shotgun metagenomics
Paolo Ghensi, University of Trento, Italy

11:30 - 11:40
Dysbiosis of the subgingival microbiome: host-microbial metatranscriptomic analysis during periodontal disease progression
Jorge Frias-Lopez, University of Florida, USA

11:40 - 11:50
Monitoring of oral microbiota to prevent infectious complications in youth with and without malformation of masticatory system orthodontically treated
Wanda Baltaza, Medical University Of Warsaw, Poland

11:50 - 12:00
Microbial clusters in gingivitis and periodontitis biofilms and saliva
Kornél Kovács, University Of Szeged, Hungary

12:00 - 12:25
Panel Discussion

Industry session not included in the main event CME/CPD credit

13:50 - 14:10
Non-CME Product Theatre (not included in the main event CME/CPD credit offering).

Chairs: Jacob Stokholm, COPSAC, Denmark
& Maria Carmen Collado, Spanish National Research Council, Spain

14:30 - 14:45
Maternal and initial neonatal gut microbiota in preterm birth
Samuli Rautava, University of Turku, Finland

14:45 - 15:00
Assessment of vaginal microbiota-host interactions in pregnancy and preterm birth
David MacIntyre, Imperial College London, United Kingdom

15:00 - 15:15
Deciphering virulence factors in preterm microbiota members and their links to Necrotising Enterocolitis
Lindsay Hall, Quadram Institute, United Kingdom

15:15 - 15:25
Identification of vaginal microbiome associated with IVF pregnancy
Belen Lledo, Instituto Bernabéu, Spain

15:25 - 15:35
Detection of preterm birth by maternal urinary volatile organic compound analysis
Sam Schoenmakers, Erasmus Mc University Medical Center, The Netherlands

15:35 - 15:55
Panel Discussion

Chairs: Jаmes Versalovic, Texas Children’s Hospital and Baylor College of Medicine, USA
& Lihi Godny, Rabin Medical Center, Israel

14:30 - 14:45
The impact of fungi and fungal glycans on intestinal epithelial immune responses
Sarit Cohen Kedar, Tel Aviv University, Israel

14:45 - 15:00
Microbial based strategies for alleviating the detrimental effects of environmental pollutants
Delphine Saulnier, Germany

15:00 - 15:20
HMOs as key metabolites in structuring the microbiome community
Kjersti Aagaard, Baylor College of Medicine, USA

15:20 - 15:50
Panel Discussion

Chairs: Frank Maixner, EURAC Institute for Mummy Studies, Italy
& Mireia Valles-Colomer, University of Trento, Italy

14:30 - 14:45
Oral microbiome and IBD
Jaana Rautava, University of Helsinki, Finland

14:45 - 15:00
Using the oral cavity to unravel complex interaction between polymicrobial biofilm and host immunity
Daniel Belstrøm, University of Copenhagen, Denmark

15:00 - 15:10
Oral microbiome and local immune/inflammatory response in COVID-19 patients: a cross-sectional study
Elisabetta Caselli, University of Ferrara, Italy

15:10 - 15:20
Influence of fermented food consumption on oral microbiota and taste perception
Maria de la Paz Ibarlucea-Jerez, CSGA / PAM, France

15:20 - 15:50
Panel Discussion

Chairs: Omry Koren, Bar Ilan University, Israel
& Nicola Segata, University of Trento, Italy

16:00 - 16:15
Host microbiome interactions in Health and Disease
Eran Elinav, Weizmann Institute of Science, Israel

16:15 - 16:30
Modern stressors of the intestinal microbiota – from in vitro tools to clinical trials
Benoit Chassaing, INSERM, France

16:30 - 16:45
Panel Discussion

16:55 - 17:30
Best Posters Guided Tours

Chairs: Samuli Rautava, University of Turku, Finland
& Franco Vicariotto, Humanitas-San PIO X Hospital Milan, Italy

17:30 - 17:45
Gut microbiome as a target for pediatric food allergy prevention and treatment
Roberto Berni Canani, University of Naples Federico II, Italy

17:45 - 18:00
Thinking outside the mouse: ex-vivo dissections of host-microbiome interactions at birth
Nissan Yissachar, Bar-Ilan University, Israel

18:00 - 18:15
Microbiome of Vaginal Dysbiosis in pregnancy
Ljubomir Petricevic, Medical University of Vienna, Austria

18:15 - 18:25
Novel host-microbiome interactions reduce severe disease outcomes caused by respiratory syncytial virus (RSV) infection
Britton Strickland, Vanderbilt University Medical Center, USA

18:25 - 18:35
Cutaneous microbial compositions modulate the severity of early-onset eczema in Chinese toddlers
Ting Fan Leung, The Chinese University of Hong Kong, Hong Kong PRC

18:35 - 19:00
Panel Discussion

Chair: Kjersti Aagaard, Baylor College of Medicine, USA & Flavia Indrio, University of Bari, Italy

17:30 - 17:45
How to choose a probiotic in paediatric age
Flavia Indrio, University of Bari, Italy

17:45 - 18:00
A “Wish List” for clinical trials in microbial interventions
Elizabeth Hohmann, Harvard Medical School, USA

18:00 - 18:15
Using human intestinal organoids to inform clinical trials
Mindy Engevik, Medical University of South Carolina, USA

18:15 - 18:45
Panel Discussion

Chairs: Gary G. Borisy, Forsyth Institute, USA & Pia Pannaraj, University of Southern California, USA

17:30 - 17:45
Changes in the microbiome during pregnancy
Mervi Gursöy, University of Turku, Finland

17:45 - 18:00
Oral microbiota and pregnancy outcomes
Leonides Fernandez, Complutense University of Madrid, Spain

18:00 - 18:15
Breastfeeding as a continuation of pregnancy
Pia Pannaraj, University of Southern California, USA

18:15 - 18:45
Panel Discussion

Chair: Omry Koren, Bar Ilan University, Israel

Times are changing and so are we
Erika Isolauri, University of Turku, Finland

Chair: Kjersti Aagaard, Baylor College of Medicine, USA

Redefine inflammatory bowel disease: Ileal disease is ileal disease
Iris Dotan, Rabin Medical Center, Israel

Chair: Samuli Rautava, University of Turku, Finland

Unknowns and strain-level profiling of the oral microbiome
Nicola Segata, University of Trento, Italy

Chair: Nicola Segata, University of Trento, Italy

09:05 - 09:20
Using data-driven genomic science to develop “Bugs as Drugs”
Trevor Lawley, Sanger Institute, UK

09:20 - 09:35
Advancing translational microbiome research by meta-omic approaches
Federica del Chierico, Bambino GesĂą Children's Hospital, Italy

09:35 - 09:50
Revealing microbiome function with stable isotope probing
David Berry, University of Vienna, Austria

09:50 - 10:15
Panel Discussion

10:20 - 10:35
Non-CME Product Theatre (not included in the main event CME/CPD credit offering).

Chair: Kjersti Aagaard, Baylor College of Medicine, USA

10:45 - 11:00
Practical microbiome-based interventions from a holobiont perspective: PPaX (The Prevention of Prematurity and Xylitol Trial): Cluster randomized trial of xylitol chewing gum on prevention of preterm birth in Malawi
Kjersti Aagaard, Baylor College of Medicine, USA

11:00 - 11:15
The impact of Westernization on the human gut microbiome
Adrian Tett, University of Vienna, Austria

11:15 - 11:30
Panel Discussion

in collaboration with The Food and Agriculture Organization of the United Nations (FAO)

Chairs: Fanette Fontaine, FAO, Italy
& Iris Dotan, Rabin Medical Center, Israel
& Erika Isolauri, University of Turku, Finland

11:30 - 11:45
The future of personalised nutrition
Tim Spector, King's College London, UK

11:45 - 12:00
The European CSA Human Microbiome Action (2021-2024)
Joel Dore, Inrae, France

12:00 - 12:15
Microbiome friendly healthy diet - food system perspectives
Fanette Fontaine, FAO, Italy

12:15 - 12:30
Microbiome and regulatory science: role in the healthy dietary transition
Yolanda Sanz, Spanish National Research Council, Spain

12:30 - 13:00
Panel Discussion

13:00 - 13:15